Beneteau designs, manufactures and sells yachts and powerboats through an international network of dealers. Co. also designs, manufactures and sells mobile homes. Its operations can be divided into two segments: The Boats segment and the Leisure Homes segment. The Boats segment groups together the activities for manufacturing and marketing boats with a customer base made up of dealers; The Leisure Homes segment groups together the activities for manufacturing and marketing mobile homes with a customer base made up of campsites and wholesalers, and the the activities for manufacturing and marketing wood-frame houses. Some of Co.'s brands are Beneteau, Jeanneau, CNB, IRM and O'Hara.

Bone Therapeutics is a biotechnology company with an advanced clinical pipeline of cell products for orthopaedic conditions and bone diseases (two Phase II/III and three Phase I/II clinical studies). These areas are characterized by high unmet medical needs due to the lack of efficacious and safe, non-invasive, treatments. Co. has two products in clinical trials, its allogeneic bone cell therapy product, ALLOB®, and its autologous bone cell therapy product, PREOB®. Co. is also conducting preclinical research on next generation products, such as combined cell-matrix products for large bone defects and maxillofacial.

Linedata Services. Linedata Services SA is a France-based company that provides software and service solutions in the area of investment, employee savings, insurance and savings, leasing and credit, and Software as a Service. Linedata Services offers solutions in six complementary areas: Implementation Services, Hosting and SAAS, Training Services, Client Support, Professional Services and Buy Side Managed Services. The Company offers asset management solutions that cover various aspects of the investment process. Its leasing and credit finance solutions cover consumer credit, car finance, professional finance and syndicated loans, and offer contract management, including automated administrative procedures. The Company's insurance and savings solutions cover employee savings, retirement savings and life insurance. The Company operates through several subsidiaries, including Linedata Technologies Tunisie SA, LD Services Inc and Fimasys Espana SL, among others.

Valneva, together with its subsidiaries, is focused on vaccine development and antibody discovery. Co. generates revenue from both its marketed product, a vaccine for the prevention of Japanese encephalitis (IXIARO®/JESPECT®), commercial partnerships around a portfolio of product candidates and licensed technology platforms (EB66® cell line, VIVA,Screen antibody discovery technology, and the IC31® adjuvant) developed by Co. Related business activities include product research and development, regulatory and clinical activities, manufacturing of commercial product and advanced clinical product candidates, as well as administrative, corporate development, and marketing and sales activities.